FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982508997> ?p ?o ?g. }

• W1982508997 endingPage "57" @default.
• W1982508997 startingPage "52" @default.
• W1982508997 abstract "For locally advanced prostate cancer, the results of radiotherapy are improved by combination with androgen deprivation therapy. Volume reduction achieved with neoadjuvant hormonal treatment can facilitate dose escalation without increasing the toxicity. The optimal duration of hormonal treatment, however, is unknown. The endpoint of this study is the optimal duration of androgen deprivation for prostate volume reduction in a cohort of patients scheduled for external beam radiotherapy. Twenty patients scheduled for external beam radiotherapy with cT2-3No/xMo prostate cancer were treated with a luteinizing hormone releasing hormone agonist (busereline) and nonsteroidal anti-androgen (nilutamide) for 9 months consecutively. Repeated CT scan examination was performed 3-monthly to measure prostate volumes until the start of radiation therapy. The analysis of volume reduction was performed with the Wilcoxon signed ranks test. The baseline median prostate volume for the cohort of patients was 82 cc (95% CI: 61–104 cc) with a median volume reduction of 31% (95% CI: 26%–35%) (P < 0.0001) after 3 months of androgen deprivation. Between 3 and 6 months, a median volume reduction of 9% (95% CI: 4%–14%) (P < 0.0001) was observed. The effect was more pronounced in large prostates (>60 cc) than in small prostates (≤60 cc). In the total cohort of patients no significant volume reduction occurred between 6 and 9 months of maximal androgen blockade (MAB). In this study, we have shown that the most significant prostate volume reduction is achieved after 3 months of MAB with a maximum reduction after 6 months. Therefore, the optimal duration of neoadjuvant androgen deprivation to reduce prostate volume before prostate cancer radiotherapy is 6 months. In small prostates 3 months of hormonal treatment may be enough for maximal volume reduction." @default.
• W1982508997 created "2016-06-24" @default.
• W1982508997 creator A5011330181 @default.
• W1982508997 creator A5023267199 @default.
• W1982508997 creator A5030962499 @default.
• W1982508997 creator A5035139320 @default.
• W1982508997 creator A5047703055 @default.
• W1982508997 creator A5062519984 @default.
• W1982508997 creator A5069087161 @default.
• W1982508997 date "2011-01-01" @default.
• W1982508997 modified "2023-10-01" @default.
• W1982508997 title "Neoadjuvant androgen deprivation for prostate volume reduction: The optimal duration in prostate cancer radiotherapy" @default.
• W1982508997 cites W1868380765 @default.
• W1982508997 cites W1964197153 @default.
• W1982508997 cites W1969187009 @default.
• W1982508997 cites W1972627363 @default.
• W1982508997 cites W1975096840 @default.
• W1982508997 cites W1977062724 @default.
• W1982508997 cites W1982618467 @default.
• W1982508997 cites W1987128343 @default.
• W1982508997 cites W1988049317 @default.
• W1982508997 cites W1996809772 @default.
• W1982508997 cites W1999919666 @default.
• W1982508997 cites W2021724776 @default.
• W1982508997 cites W2032936668 @default.
• W1982508997 cites W2038861316 @default.
• W1982508997 cites W2040826923 @default.
• W1982508997 cites W2056643793 @default.
• W1982508997 cites W2057157268 @default.
• W1982508997 cites W2078162122 @default.
• W1982508997 cites W2086786344 @default.
• W1982508997 cites W2089488597 @default.
• W1982508997 cites W2091094692 @default.
• W1982508997 cites W2097532477 @default.
• W1982508997 cites W2098815853 @default.
• W1982508997 cites W2117584600 @default.
• W1982508997 cites W2117886818 @default.
• W1982508997 cites W2129917133 @default.
• W1982508997 cites W2137484217 @default.
• W1982508997 cites W2140362543 @default.
• W1982508997 cites W2151484054 @default.
• W1982508997 cites W2152182740 @default.
• W1982508997 cites W2153674426 @default.
• W1982508997 cites W2155235160 @default.
• W1982508997 cites W2157028940 @default.
• W1982508997 cites W2157797729 @default.
• W1982508997 cites W2158535318 @default.
• W1982508997 cites W2160817777 @default.
• W1982508997 cites W4243651860 @default.
• W1982508997 cites W91986305 @default.
• W1982508997 doi "https://doi.org/10.1016/j.urolonc.2009.03.024" @default.
• W1982508997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19523856" @default.
• W1982508997 hasPublicationYear "2011" @default.
• W1982508997 type Work @default.
• W1982508997 sameAs 1982508997 @default.
• W1982508997 citedByCount "34" @default.
• W1982508997 countsByYear W19825089972012 @default.
• W1982508997 countsByYear W19825089972013 @default.
• W1982508997 countsByYear W19825089972014 @default.
• W1982508997 countsByYear W19825089972015 @default.
• W1982508997 countsByYear W19825089972016 @default.
• W1982508997 countsByYear W19825089972017 @default.
• W1982508997 countsByYear W19825089972020 @default.
• W1982508997 countsByYear W19825089972021 @default.
• W1982508997 countsByYear W19825089972022 @default.
• W1982508997 countsByYear W19825089972023 @default.
• W1982508997 crossrefType "journal-article" @default.
• W1982508997 hasAuthorship W1982508997A5011330181 @default.
• W1982508997 hasAuthorship W1982508997A5023267199 @default.
• W1982508997 hasAuthorship W1982508997A5030962499 @default.
• W1982508997 hasAuthorship W1982508997A5035139320 @default.
• W1982508997 hasAuthorship W1982508997A5047703055 @default.
• W1982508997 hasAuthorship W1982508997A5062519984 @default.
• W1982508997 hasAuthorship W1982508997A5069087161 @default.
• W1982508997 hasConcept C121608353 @default.
• W1982508997 hasConcept C126322002 @default.
• W1982508997 hasConcept C126894567 @default.
• W1982508997 hasConcept C143998085 @default.
• W1982508997 hasConcept C2776235491 @default.
• W1982508997 hasConcept C2777899217 @default.
• W1982508997 hasConcept C2777911890 @default.
• W1982508997 hasConcept C2780192828 @default.
• W1982508997 hasConcept C509974204 @default.
• W1982508997 hasConcept C71315377 @default.
• W1982508997 hasConcept C71924100 @default.
• W1982508997 hasConcept C72563966 @default.
• W1982508997 hasConceptScore W1982508997C121608353 @default.
• W1982508997 hasConceptScore W1982508997C126322002 @default.
• W1982508997 hasConceptScore W1982508997C126894567 @default.
• W1982508997 hasConceptScore W1982508997C143998085 @default.
• W1982508997 hasConceptScore W1982508997C2776235491 @default.
• W1982508997 hasConceptScore W1982508997C2777899217 @default.
• W1982508997 hasConceptScore W1982508997C2777911890 @default.
• W1982508997 hasConceptScore W1982508997C2780192828 @default.
• W1982508997 hasConceptScore W1982508997C509974204 @default.
• W1982508997 hasConceptScore W1982508997C71315377 @default.
• W1982508997 hasConceptScore W1982508997C71924100 @default.
• W1982508997 hasConceptScore W1982508997C72563966 @default.

• next